In mammals, melanin is the major pigment for the color of human skin and hair. It is synthesized in the melanosomes of melanocytes. This process, called melanogenesis, is a complex phenomenon that occurs in melanocytes by melanogen, cytokine and melanogenic enzymes, such as tyrosinase, tyrosinase-related protein 1 (TRP-1) and tyrosinase-related protein 2 (TRP-2).
4)
Several known natural melanin synthesis inhibitors, including arbutin and kojic acid, have already been the focus of studies, and are currently being utilized as cosmetic additives. 5) However, it is necessary to find safer and more effective skin-whitening agents, because of the carcinogenic potential of kojic acid as well as its weak whitening effect. A great deal of attention has continuously focused on the application of natural products in the cosmetics industry. 6, 7) Zeolites have crystalline open framework structures constructed from SiO 4 and AlO 4 tetrahedra linked through oxygen bridges. [8] [9] [10] Each oxygen atom is shared by two silicon or aluminum atoms. Zeolite is known that silicates and aluminosilicates possess biological activity and also are nontoxic agents. They have been studied in safe oral contrast agent for human magnetic imaging work 11) and in the context of animal feeds. 12) Recently, zeolite was found to be a new adjuvant in anticancer therapy, 10) and demonstrated to decreases TiO 2 -photosensitized reactive oxygen species (ROS) generation in cultured human skin fibroblasts. 10, 13) In the present study, we demonstrate that zeolite 4A inhibits MITF-mediated tyrosinase expression and melanin synthesis via increasing extracellular signal-regulated kinase (ERK) activity in B16F10 melanoma cells.
MATERIALS AND METHODS

Materials
Fetal bovine serum (FBS), Dulbecco's modified Eagle's medium and other medium supplements were purchased from Invitrogen (Carlsbad, NM, U.S.A.). Synthetic melanin, L-dihydroxyphenylalanine (L-DOPA), kojic acid and mushroom tyrosinase were purchased from Sigma-Aldrich Co. (St. Louis, MO, U.S.A.). Alpha-MSH was purchased from Calbiochem (St. Louis, MO, U.S.A.). Anti-pERK (Thr 202, Tyr 204), anti-ERK and anti-pAKT were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Anti-tyrosinase antibody, anti-MITF (C-5) and anti-tubulin (DM1A) were purchased from NeoMarker (Fremont, CA, U.S.A.).
Cell Cultures B16F10 melanoma cells were generously provided by Dr. Kyoung-Chan Park (Department of Dermatology, Seoul National University), cultured in DMEM (13.4 mg/ml Dulbecco's modified Eagle's medium, 10 mM HEPES, 143 U/ml benzylpenicillin potassium, 100 mg/ml streptomycin sulfate, 24 mM NaHCO 3 , pH 7. ) in a 96-well microtiter plate were incubated in the presence or absence of capsaicin at 37°C for 24 h. After incubation, 10 ml of MTT (5 mg/ml) solution was added and the mixture was incubated for 4 additional hours. The supernatant was then removed carefully, and 100 ml of dimethylsulfoxide (DMSO) was added to dissolve formazan crystals. Optical density (OD) at 570 nm was read using an enzyme-linked immunosorbent assay (ELISA)-reader.
Measurement of Melanin Content Extracellular melanin release was measured as previously described. 14, 15) Briefly, B16F10 cells (1ϫ10 5 cells/well) were seeded into 6 well tissue culture plates. After treatment, cells were incubated for the desired time. Alpha-MSH (0.1 mM) was then added and cells were treated with increasing concentrations of zeolite 4A (0.16-100 mg/ml) for 72 h. For measurement of melanin content, 200 ml aliquots of medium were then placed in 96-well plates and OD was measured at 400 nm using an ELISA reader. Depigmenting activity was expressed by the percentage of melanin content in zeolite 4A treated melanoma cells relative to that of untreated melanoma cells.
Tyrosinase Activity Tyrosinase activity was determined as previously described with some modification. 14, 16) Briefly, B16F10 cells were treated with either a-MSH alone or a-MSH plus zeolite 4A (0.8-100 mg/ml) or kojic acid (10 mM) for 48 h, washed with ice-cold PBS, and lysed with phosphate buffer (pH 6.8) containing 1% Triton X-100. They were then disrupted by freeze-thawing and the lysate was clarified by centrifuging at 10000ϫg for 5 min. After quantifying protein levels using the Bradford assay and adjusting for concentrations with lysis buffer, 90 ml of each lysate was placed in a well of a 96-well microtiter plates, and 10 mM of 10 mM L-DOPA was added. Absorbance was measured at 475 nm every 10 min for at least 1 h using an ELISA reader while incubating at 37°C.
A cell-free assay system was used to investigate the direct effects of zeolite 4A on tyrosinase activity. Briefly, 70 ml of phosphate buffer containing zeolite 4A (0.8-100 mg/ml) or kojic acid (100 mM) were mixed with 20 ml of 10 mg/ml mushroom tyrosinase, and 10 ml of 10 mM L-DOPA was then added. After incubation at 37°C for 30 min, absorbance was measured at 475 nm.
Tyrosinase Zymography Tyrosinase activity was determined by zymography as previously described. [17] [18] [19] B16F10 melanoma cells were treated with either a-MSH alone or a-MSH plus zeolite 4A for 48 h. To identify tyrosinase, cells were lysed in 0.1 M sodium phosphate buffer (pH 6.8) containing 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml aprotinin and 10 mg/ml leupeptin. An equal amount of the lysate was mixed with protein sample buffer without b-mercaptoethanol, and was resolved on sodium dodecyl sulfate (SDS)-polyacrylamide gel by electrophoresis (PAGE) without boiling. Gel containing tyrosinase activity was rinsed in 200 ml of 100 mM sodium phosphate buffer (pH 6.8) and equilibrated at room temperature with gentle shaking. After 30 min, the rinse buffer was replaced with fresh buffer. After repeating the rinse procedure once again, the gel was transferred into 200 ml of a staining solution containing the rinse buffer supplemented with 5 mM L-DOPA, and incubated in the dark at 37°C for 3 h. Tyrosinase activity was visualized in the gel as a dark melanincontaining band.
Western Blot Analysis Cells were lysed in RIPA buffer (50 mM Tris, pH 7.4; 150 mM NaCl; 1% NP-40; 0.5% sodium deoxycholate; 0.1% SDS) supplemented with protease inhibitor cocktail (Roche Applied Science, Mannheim, Germany) or lysed directly in 2X SDS-PAGE sample buffer, and subjected to Western blot analysis using specific antibodies. Twenty micrograms of total protein per lane was loaded onto a SDS-polyacrylamide gel. After electrophoresis, bands of protein were transferred to a polyvinylidene difluoride (PVDF) membrane (Amersham-Pharmacia Biotech, Piscataway, NJ, U.S.A.). Blocking and primary antibodies were incubated in phosphate-buffered saline containing 5% non-fat dry milk and 0.1% Tween-20, and this was followed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies (Zymed Laboratories, South San Francisco, CA, U.S.A.). Peroxidase activity was detected by chemiluminescence using a West Pico Western blot detection reagent according to the manufacturer's instructions (Pierce, Rockford, IL, U.S.A.).
RESULTS
Zeolite 4A Has No Cytotoxic Effect on B16F10 Cells
The structure of zeolite 4A is shown in Fig. 1 . Zeolite molecular sieves are crystalline, highly porous materials, which belong to the class of aluminosilicates. These crystals are characterized by a three-dimensional pore system, with pores of precisely defined diameter. To determine whether zeolite 4A has a cytotoxic effect on B16F10 cells, we treated zeolite 4A at 0.16-100 mg/ml for 24 h and measured cell viability using the MTT assay. Zeolite 4A was not cytotoxic to B16F10 cells in the concentration range 0.16-100 mg/ml (Fig. 2) .
Zeolite 4A Inhibits a a-MSH-Induced Melanin Synthesis in B16F10 Cells The effect of zeolite 4A on the melanogenesis of B16F10 cells was examined. B16F10 cells treated with zeolite 4A showed a dose-dependent decrease in extracellular melanin release (Fig. 3A) . In mammals, a-MSH is required for the development of pigmentation. 1) To determine whether zeolite 4A inhibits a-MSH-induced melanin synthe- Fig. 1 . The Structure of Zeolite 4A sis in B16F10 cells, we measured a-MSH-induced melanin production. First, we confirmed the effect of a-MSH-induced melanin synthesis in B16F10 cells. Alpha-MSH increased the amount of melanin in media (Fig. 3B) . In addition, kojic acid, a positive control, inhibited a-MSH-induced melanogenesis (data not shown), and zeolite 4A treatment also reduced a-MSH-induced melanin release in a dose-dependent manner (Fig. 3C) . These results indicate that zeolite 4A inhibited not only extracellular melanin levels but also a-MSH-induced melanin synthesis.
Zeolite 4A Reduces Tyrosinase Protein Expression but Not Tyrosinase Activity Melanogenesis is known to be controlled by an enzymatic cascade, which is regulated at the levels of tyrosinase, TRP-1, and TRP-2. 20) To investigate the mechanism of depigmenting action shown by zeolite 4A, we carried out zymography and the measurement of tyrosinase activity in the cell or cell-free assay system. B16F10 cells were treated with either a-MSH alone or a-MSH plus zeolite 4A, and their lysate was resolved on the gel by electrophoresis (Fig. 4B ). As shown in Fig. 4A , a-MSH-induced tyrosinase activity which was inhibited in a dose-dependent manner.
We next investigated the direct effect of zeolite 4A on tyrosinase activity using mushroom tyrosinase. Interestingly, zeolite 4A did not show inhibitory effects on L-DOPA oxidation activity of the cell-free tyrosinase (Fig. 4C) . Our results indicate that zeolite 4A may reduce pigmentation by way of an indirect nonenzymatic mechanism. To investigate whether zeolite 4A can influence tyrosinase expression, we performed the Western blotting assay. As shown in Fig. 4D , a-MSHinduced tyrosinase expression was inhibited in a dose-dependent manner by zeolite 4A. Therefore, these data suggest that zeolite 4A inhibited a-MSH-induced tyrosinase protein expression.
Zeolite 4A Inhibits the MITF Expression and Stimulates the ERK Phosphorylation MITF is a transcription factor that effectively transactivates the expression of tyrosinase and its related genes by binding to their common promoters.
2) We examined the MITF expression after zeolite 4A treatment. As shown in Fig. 5A , a-MSH-induced MITF expression was inhibited in a dose-dependent manner by zeolite 4A. The Akt signaling pathway has been reported to be involved in the melanogenesis of G361 and B16 melanoma cells, 16, [21] [22] [23] we investigated whether zeolite 4A influences the Akt signaling pathway, but we found that it did not (Fig.  5B) . Furthermore, zeolite 4A had no effect on CREB phosphorylation (data not shown), which is known to activate the MITF promoter.
Several reports have suggested that ERK activation phosphorylates MITF and its subsequent degradation by ubiquitination and degradation, 23, 24) we examined the MITF expression after zeolite 4A treatment. As shown in Fig. 5A , a-MSH-induced MITF expression was inhibited in a dose-dependent manner by zeolite 4A. We next examined whether zeolite 4A induces ERK activation. As shown in Fig. 5B , zeolite 4A induced phosphorylation of ERK1/2 which was made evident 15 min after adding zeolite 4A. As zeolite 4A activates the ERK, we investigated the influences on suppressive effect of zeolite 4A on melanogenesis of PD98059, a specific inhibitor of MEK or ERK. As shown in Fig. 5C , zeolite 4A-related inhibition of melanogenesis resulted in lower levels of expression of tyrosinase. PD98059 inhibits abrogated zeolite 4A-mediated down regulation of tyrosinase expression, and activation of MEK/ERK signaling. These results indicate that zeolite 4A may regulate MEK/ERK signaling pathways involved in melanogenesis. 74 Vol. 33, No. 1 Fig. 2 . Effect of Zeolite 4A on B16F10 Cell Viability Cytotoxicity of zeolite 4A on cultures of B16F10 melanoma cells. Cells treated with zeolite 4A at 0.16-100 mg/ml for 24 h. Cells viability was determined using the MTT assays. Results are expressed as a percent viability relative to vehicle-treated controls. 1 mM) and zeolite 4A at 0.8-100 mg/ml for 72 h. * pϽ0.05, * * pϽ0.01, and * * * pϽ0.001 in (A) and (B) as compared with untreated control. * pϽ0.05; * * pϽ0.01; * * * pϽ0.001 in (C) as compared with a-MSH-stimulated cells.
DISCUSSION
Numerous natural compounds are commonly used to skinwhitening agents. Zeolites are used in very different fields where advantage is taken of the specific properties of zeolitic materials. It has been extensively used in various applications as constructions, adsorption wastewater treatment and agriculture. Synthetic zeolites also are used a medical. It is known that silicates and aluminosilicates possess biological activity. 25) Recently, Talc and silica have been used in skin care, while well defined structures and catalytic activity make aluminosilicates an attractive model system for protein and enzyme mimetics. 10, 25) This study demonstrates that zeolite 4A is skin-whitening agents that act via down-regulation of tyrosinase expression. We found that zeolite 4A inhibited melanin production in a dose-dependent manner (Fig. 3A) , which was not a cytotoxic effect to B16F10 melanoma cells (Fig. 2) . In addition, zeolite 4A also inhibited a-MSH-induced melanin synthesis (Fig.  3C) . Tyrosinase has been demonstrated to catalyze the ratelimiting step of melanin biosynthesis, and it is the primary target of kojic acid which is used as cosmetic and medical material with efficient depigmenting effects. 4, 26, 27) Zeolite 4A inhibited a-MSH-induced tyrosinase activity in the cell lysate and gel (Figs. 4A, B) . However, as shown in Fig. 4C , zeolite 4A did not directly inhibit tyrosinase activity, which indicated the involvement of different mechanisms. These results suggest that reduced pigmentation by zeolite 4A might be attributed to the effect of zeolite 4A upon the signaling pathways regulating tyrosinase.
For a better understanding of the depigmenting action of zeolite 4A targeting tyrosinase synthesis, Western immunoblot analysis was carried out. Zeolite 4A attenuated a-MSH-induced tyrosinase synthesis in a dose-dependent manner (Fig. 4D) . Therefore, depigmenting action of zeolite 4A in B16F10 cells may be attributed to its down-regulatory mechanism of tyrosinase expression. In addition, our results showed that zeolite 4A reduced MITF protein levels (Fig.  5A) . MITF controls pigmentation by regulating the expression of melanogenic enzymes such as tyrosinase, TRP-1, and TRP-2. 20, 28) It has been reported that ERK is an important regulator of melanogenesis because ERK activation induces MITF phosphorylation and its subsequent degradation, and thus reduces melanin synthesis. In our experiments, zeolite 4A obviously stimulated the phosphorylation of ERK and inhibited the synthesis of melanin in B16F10 cells (Figs.  5B, C) .
Interestingly, Akt signaling pathway has been reported to be involved in the melanogenesis of G361 and B16 melanoma cells. 16, 22) However, Pavelic et al. 10) reported that natural zeolite clinoptilolite decrease phosphorylation of Akt in murine fibrosarcoma. In our data, no changes in the phosphorylation of Akt levels were observed by zeolite 4A (Fig.  5B) . Here we provide evidence that zeolite 4A inhibits melanin synthesis through the degradation of MITF by ERK activation in B16F10 melanoma cells, it has remained unclear how ERK activation by zeolite 4A. To resolve this issue further studies such as MITF degradation, MITF promoter assay and ERK upstream kinase are required.
In conclusion, zeolite 4A suppresses cellular melanin biosynthesis and tyrosinase activity in a-MSH-induced B16F10 melanoma cells, suppressing the expression of MITF, tyrosinase, and increasing ERK activity. These results suggest that zeolite 4A inhibits melanogenesis by activating the MEK/ERK pathway-mediated suppression of MITF and its downstream target gene including tyrosinase. Thus, our results suggest that zeolite 4A might be useful as a potential skin-whitening agent.
